25
Participants
Start Date
November 6, 2020
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2028
Vyxeos 44 MG / 100 MG Liposome Injection
Vyxeos®/CPX-351 will be infused in 90 minutes on day 1, 3 and 5 only, 3 hours after the end of clofarabine (if administered on the same day).
Clofarabine
Clofarabine infusion will be given according to the assigned dose level, over 2 hours IV, daily on day 2-6 (for 5 consecutive days).
RECRUITING
St. Anna Kinderspital, Vienna
RECRUITING
Rigshospitalet, Copenhagen
RECRUITING
Universitätsklinikum Augsburg, Augsburg
RECRUITING
Charité Berlin, Berlin
RECRUITING
University Children´s Hospital III Essen, Essen
RECRUITING
Universitätsklinikum Frankfurt, Frankfurt
RECRUITING
Universitätsklinikum Hamburg-Eppendorf, Hamburg
RECRUITING
Clinica Pediatrica Fondazione MBBM, Monza
RECRUITING
Ospedale Pediatrico Bambino Gesu (OPBG), Roma
RECRUITING
Hospital Sant Joan de Déu, Barcelona
RECRUITING
Hospital Vall D'Hebron, Barcelona
RECRUITING
Hospital Infantil Universitario Niño Jesús, Madrid
RECRUITING
Princess Maxima Center, Utrecht
Collaborators (1)
Jazz Pharmaceuticals
INDUSTRY
Princess Maxima Center for Pediatric Oncology
OTHER